Company intelligence / Profile preview

Fytocare

Ownership: Private
Development stage: Commercial

Overview

Fytocare-branded pharmaceutical and nutraceutical products are commercially available in India. These include protein powders enriched with DHA, methylcobalamin injections for vitamin B12 deficiency, and ginseng-based antioxidant capsules. No clinical trial results are reported; these are marketed as supplements or standard therapies.

Therapeutic areas: Metabolic DisordersHematology
Modalities: Small moleculeProtein supplement
Industry: Food & Nutrition

Beyond the preview

Go deeper on Fytocare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fytocare.

Explore the full profile